Bioadaptives, Inc.
BDPT- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001575142
No open-market purchases or sales by Bioadaptives, Inc. insiders were filed in the last 90 days; no institution reported holding it in 13F filings for Q2 2026; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Bioadaptives, Inc. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Bioadaptives, Inc., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Frissora Mark P | Director | – | Sep 3, 2026 | 12 |
| Dissanayake Gimhana Sasanka | Director | 125,000 | Dec 3, 2024 | 0 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| May 5, 2025 (view filing) | Apr 9 | 26 daysLate | Frissora Mark PDirector | PPurchase | +4.49M | $0.0752 | +$299.8K | –1 after | Derivative2 lots |
| Dec 3, 2024 (view filing)8:30 PM ET | Nov 22 | 11 daysLate | Dissanayake Gimhana SasankaDirector | PPurchaseCommon | +125.0K | $0.085 | +$10.6K | New position125.0K after |